CURE:AU:AU-ETFS S&P Biotech ETF (AUD)

ETF | Others |

Last Closing

USD 48.11

Change

-0.52 (-1.07)%

Market Cap

USD 0.04B

Volume

771.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

ETFs Containing CURE:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.09% 42% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.09% 30% F 57% F
Trailing 12 Months  
Capital Gain 26.61% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.61% 82% B 75% C
Trailing 5 Years  
Capital Gain 0.02% 31% F 58% F
Dividend Return 13.06% 55% F 42% F
Total Return 13.08% 32% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain -2.67% N/A N/A 36% F
Dividend Return -0.28% N/A N/A 37% F
Total Return 2.39% N/A N/A 46% F
Risk Return Profile  
Volatility (Standard Deviation) 21.75% N/A N/A 72% C
Risk Adjusted Return -1.30% N/A N/A 37% F
Market Capitalization 0.04B 10% F 46% F

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.